BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 38165902)

  • 21. TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer.
    Qiao HY; Zhang Q; Wang JM; Jiang JY; Huyan LY; Yan J; Li C; Wang HQ
    Cancer Lett; 2022 Mar; 529():85-99. PubMed ID: 34973391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Putative Roles of SETBP1 Dosage on the SET Oncogene to Affect Brain Development.
    Antonyan L; Ernst C
    Front Neurosci; 2022; 16():813430. PubMed ID: 35685777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical delineation of SETBP1 haploinsufficiency disorder.
    Jansen NA; Braden RO; Srivastava S; Otness EF; Lesca G; Rossi M; Nizon M; Bernier RA; Quelin C; van Haeringen A; Kleefstra T; Wong MMK; Whalen S; Fisher SE; Morgan AT; van Bon BW
    Eur J Hum Genet; 2021 Aug; 29(8):1198-1205. PubMed ID: 33867525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SETBP1 mutations in two Thai patients with Schinzel-Giedion syndrome.
    Suphapeetiporn K; Srichomthong C; Shotelersuk V
    Clin Genet; 2011 Apr; 79(4):391-3. PubMed ID: 21371013
    [No Abstract]   [Full Text] [Related]  

  • 25. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
    Piazza R; Valletta S; Winkelmann N; Redaelli S; Spinelli R; Pirola A; Antolini L; Mologni L; Donadoni C; Papaemmanuil E; Schnittger S; Kim DW; Boultwood J; Rossi F; Gaipa G; De Martini GP; di Celle PF; Jang HG; Fantin V; Bignell GR; Magistroni V; Haferlach T; Pogliani EM; Campbell PJ; Chase AJ; Tapper WJ; Cross NC; Gambacorti-Passerini C
    Nat Genet; 2013 Jan; 45(1):18-24. PubMed ID: 23222956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatic SETBP1 mutations in myeloid malignancies.
    Makishima H; Yoshida K; Nguyen N; Przychodzen B; Sanada M; Okuno Y; Ng KP; Gudmundsson KO; Vishwakarma BA; Jerez A; Gomez-Segui I; Takahashi M; Shiraishi Y; Nagata Y; Guinta K; Mori H; Sekeres MA; Chiba K; Tanaka H; Muramatsu H; Sakaguchi H; Paquette RL; McDevitt MA; Kojima S; Saunthararajah Y; Miyano S; Shih LY; Du Y; Ogawa S; Maciejewski JP
    Nat Genet; 2013 Aug; 45(8):942-6. PubMed ID: 23832012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of a novel
    Yang H; Liu Z; Chen D; Lin W; Wang L; Chen T; Wang R; Yan X
    Front Pediatr; 2022; 10():920741. PubMed ID: 36147799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic SETBP1 mutations in myeloid neoplasms.
    Makishima H
    Int J Hematol; 2017 Jun; 105(6):732-742. PubMed ID: 28447248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of
    Leonardi E; Bettella E; Pelizza MF; Aspromonte MC; Polli R; Boniver C; Sartori S; Milani D; Murgia A
    Front Neurol; 2020; 11():593446. PubMed ID: 33391157
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel SETBP1 mutation in a chinese family with intellectual disability.
    Wang L; Wang XD; Yang B; Wang XM; Peng YQ; Tan HJ; Xiao HM
    BMC Med Genomics; 2023 Oct; 16(1):233. PubMed ID: 37798664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel
    Vrkić Boban I; Sekiguchi F; Lozić M; Miyake N; Matsumoto N; Lozić B
    J Pediatr Genet; 2022 Jun; 11(2):135-138. PubMed ID: 35769969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer Patients.
    Torrejón B; Cristóbal I; Caramés C; Prieto-Potín I; Chamizo C; Santos A; Sanz-Alvarez M; Serna-Blasco R; Luque M; Madoz-Gúrpide J; Rojo F; García-Foncillas J
    World J Surg; 2018 Nov; 42(11):3771-3778. PubMed ID: 29796729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unusual neuroradiological features in Schinzel-Giedion syndrome: a novel case.
    Lestner JM; Chong WK; Offiiah A; Kefas J; Vandersteen AM
    Clin Dysmorphol; 2012 Jul; 21(3):152-154. PubMed ID: 22473152
    [No Abstract]   [Full Text] [Related]  

  • 34. Speech and language deficits are central to SETBP1 haploinsufficiency disorder.
    Morgan A; Braden R; Wong MMK; Colin E; Amor D; Liégeois F; Srivastava S; Vogel A; Bizaoui V; Ranguin K; Fisher SE; van Bon BW
    Eur J Hum Genet; 2021 Aug; 29(8):1216-1225. PubMed ID: 33907317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.
    Inoue D; Kitaura J; Matsui H; Hou HA; Chou WC; Nagamachi A; Kawabata KC; Togami K; Nagase R; Horikawa S; Saika M; Micol JB; Hayashi Y; Harada Y; Harada H; Inaba T; Tien HF; Abdel-Wahab O; Kitamura T
    Leukemia; 2015 Apr; 29(4):847-57. PubMed ID: 25306901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Missense variant in CCDC22 causes X-linked recessive intellectual disability with features of Ritscher-Schinzel/3C syndrome.
    Kolanczyk M; Krawitz P; Hecht J; Hupalowska A; Miaczynska M; Marschner K; Schlack C; Emmerich D; Kobus K; Kornak U; Robinson PN; Plecko B; Grangl G; Uhrig S; Mundlos S; Horn D
    Eur J Hum Genet; 2015 May; 23(5):633-8. PubMed ID: 24916641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BCL11A Haploinsufficiency Causes an Intellectual Disability Syndrome and Dysregulates Transcription.
    Dias C; Estruch SB; Graham SA; McRae J; Sawiak SJ; Hurst JA; Joss SK; Holder SE; Morton JE; Turner C; Thevenon J; Mellul K; Sánchez-Andrade G; Ibarra-Soria X; Deriziotis P; Santos RF; Lee SC; Faivre L; Kleefstra T; Liu P; Hurles ME; ; Fisher SE; Logan DW
    Am J Hum Genet; 2016 Aug; 99(2):253-74. PubMed ID: 27453576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. hTFtarget: A Comprehensive Database for Regulations of Human Transcription Factors and Their Targets.
    Zhang Q; Liu W; Zhang HM; Xie GY; Miao YR; Xia M; Guo AY
    Genomics Proteomics Bioinformatics; 2020 Apr; 18(2):120-128. PubMed ID: 32858223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia.
    Choi HW; Kim HR; Baek HJ; Kook H; Cho D; Shin JH; Suh SP; Ryang DW; Shin MG
    Ann Lab Med; 2015 Jan; 35(1):118-22. PubMed ID: 25553291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.